PASO Archives - Page 3 of 3 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: PASO Special Report

Patient Access Solutions, Inc. PASO – Special Report

We’re beginning this fresh trading week with a special report on a stock you’re not going to want to overlook. PASO (PASHealth) operates in the healthcare industry, for which it has adapted a wide array of services to provide solutions in a rapidly changing healthcare environment.

We are focusing upon PASO at an critical time in the company’s development, having only just announced an important step in a series of acquisitions that fall in line with its overall strategy of opening integrated health centers across New York State and in other regions of the country. Just last week, it was announced that the company had acquired a multi-specialty health and wellness facility.

It is the private practice of Dr. Donald Chiappetta in West Babylon, NY, a town on Long Island just a short drive from the company’s other facilities in Plainview NY. The practice has been in operation for over two decades, and produces annual revenue exceeding $1.5M in serving, on average, more than 2000 patients on a monthly basis.

On the new union forged here in the new year, Dr. Chiappetta commented: “My staff and I are excited to join the Company. Integrating our practice and specialties with the Plainview facility will create a full service offering and offer our patients the ability to access our team of professionals across a larger geographic area.” (>>View Full PR)

Dr. Chiappetta has also been named Chief Operating Officer of PASO, responsible for managing day-to-day operations as well as facilitating growth both organically and through further strategic acquisitions. In addition to his private practice, he has also worked for both NFL, and Olympic athletes.

We are pleased to report that we will be conducting an exclusive interview with Dr. Chiappetta later this week via our Stock Traders Talk channel, so be sure you’re subscribed to our daily newsletter and keep an eye out for that announcement! In the meantime, take a look at why we’re interested in PASO from a technical standpoint on the chart snapshot below.

The recent bullish rise of PASO is sure to have raised some eyebrows, with considerably increased volume over the same time span. The next key area of resistance for the stock to contend with sits at .0391. We’ll be looking for the PASO to test that area in the days and weeks ahead.
____

FRESH NEWS:
Just hitting the wires this morning is another update to the PASO newsreel.

COMMACK, NY, Jan. 14, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Patient Access Solutions, Inc. (OTC PINK: PASO), a provider of technology and management solutions for the healthcare industry is proud to announce Dr. James Lederer will be joining the Company as the Director of Behavioral Health for the Group. Dr. Lederer will be based at the Plainview, NY Integrated Health facility. (>>View Full PR)
_____

For More Information on PASO Please Visit:
PASHEALTH.COM

BOCX, CIGX & PASO Inside Today’s Penny Stock Newsletter

Patient Access Solutions, Inc. PASO

Two weeks back, we reported that PASO was trading at its 52-week low, and we felt that the bottom was being solidified in place. Trading on Thursday pushed the price of PASO stock to .0009, which incidentally, could have made savvy traders 50-80% in gains.

As if the increased activity wasn’t enough to be satisfied, the company came with some post-market blockbuster news that could help fuel the continuation of momentum to close out the week strong.

PASO is a perfect example of why patience is key, even with some of our shorter-term plays, just a few weeks time can make a big difference.

HAUPPAUGE, N.Y., Sep 08, 2011 (BUSINESS WIRE) — Patient Access Solutions, Inc. (Pink Sheets: PASO), a leading provider of information technology solutions for the healthcare industry is pleased to announce its EMR management & support solution has been engaged and is being deployed with a Florida based hospital group.

The client is the largest faith based, non profit health care organization in Florida to participate in the EHR (Electronic Health Record) program and has a long standing pedigree as a national leader in the adoption of healthcare IT across its network of 6 hospitals comprising of more than 1,500 beds. This engagement serves as part of its continuing commitment to enable excellent quality care and services, will assist its more than 2,000 physicians in the adoption of Electronic Health Records in their private practices through an EHR Donation Program. The initial implementation expects to generate approximately $3 million in gross revenue over the next year for Patient Access Solutions.

Star Scientific, Inc. CIGX

We were discussing CIGX last Wednesday, at which time the PPS was sitting at 2.33. We alluded to the fact that we believed CIGX qualified as a rebound play. The stock did trade sideways for a few days, and now, over the past two days we have begun to witness some slow and steady gains.

On Thursday, CIGX cracked into the top -gainers list for NASDAQ stocks. It is always impressive when a NASDAQ stock can increase in value 7% in a single day.

Autumn was a huge season for this stock last year, when the PPS doubled in just a few short months. We are anxious to see what activity this fall season will bring to CIGX.

BioCurex, Inc BOCX

Yesterday, BOCX had some earth-shattering news, as the stock price compounded by more than 175%, and this, on forty-four times its 3-month average volume.

When momentum stocks like this hit our radar screen, we like to keep them high on our watchlist as heavy movers with a high bounce probability.

This morning, we foresee a possible gap up followed by a pullback, which we see as a good opportunity to get in for a quick flip on the bounce. Ultimately we will be watching BOCX closely for the dust to settle after yesterday’s excitement.

Here is the huge news that caused all this commotion:

BioCurex’s RECAF(TM) Blood Test for Cancer Can Prevent Two Thirds of Unnecessary Prostate Biopsies

RICHMOND, British Columbia, Sep 8, 2011 (GlobeNewswire via COMTEX) — BioCurex Inc. (OTCBB:BOCX) today announced results indicating that its RECAF blood test for cancer can prevent 70% of unnecessary prostate biopsies.

In a study to be presented at the ISOBM (International Society of Oncology and Biomarkers) annual meeting in October, BioCurex compared the performance of RECAF and free-PSA to discriminate prostate cancer from benign prostate hyperplasia (BPH), a common benign condition that requires no surgical treatment. The RECAF test outperformed the established free-PSA test by approximately 600% in its ability to prevent unnecessary prostate biopsies.

Blue Horseshoe Stock Report for 08/26/11

eMax Holdings Corp. EMXC

Early on this week, we stated that we were watching closely to see EMXC hold its level of support at .0015-.0016, as well as observe the RSI bounce off of the 50 mark; in both cases, our predictions rang true.

We like the fact that last weeks consolidation occurred on lighter-than-average volume, and that the MACD indicator is currently setting up for another bullish cross.

We know this play far too well to be under the impression that the party is over. Our patience with EMXC runs very thick.

United Treatment Centers, Inc. UTRM

UTRM had another great day of gains on Thursday just as we suspected, closing at .002 for a gain of 33%, and bringing the total gain since our re-call of the stock on Wednesday to 100%

It is not the first time that we have been extremely pleased with the performance of UTRM, and neither should it be the last.

With the bottom behind us and volume increasing, we are anxious to see how this play develops over the next couple of weeks.

Patient Access Solutions, Inc. PASO

PASO bounced off of its 52-week low of .0006 on Monday, and hit a high of .0014 that same day. Since that time, the stock has yet to firm up its bottom, and thus we are watching intently for the present selling pressure to subside.

After having released two positive statements to the press this month, PASO is still high on our watchlist.

PRs:

Visiting Nurse Service of NY Affiliate, Partners in Care, Engages Patient Access Solutions™ for Mobipen Technology

Patient Access Solutions Secures $5,000,000 Financing

We are happy to be wrapping up one heck of a week of trading on the OTC markets, and are already looking forward to kicking off more action on Monday. As the end of the Summer Doldrums rears into view, we are increasingly excited for September, and the characteristic increase in market activity that it almost always accompanies.

Blue Horseshoe Stock Report for 08/25/11

Patient Access Solutions, Inc. PASO

PASO traded more than twice its ten day average of daily volume on Wednesday, and achieved a higher low for the second consecutive day. .0011 was our previous level of support prior to this week, and now becomes our key resistance point, as the stock struggled a bit to breach that level.

Let’s take a look at the PR they released also, outlining a partnership that will increase the company’s effectiveness in addition to potentially generating three quarters of a million dollars in revenue.

We think that PASO qualifies as an undervalued stock, which is why we continue to hang in there and monitor the situation.

HAUPPAUGE, N.Y., Aug 24, 2011 (BUSINESS WIRE) — Patient Access Solutions, Inc. (Pink Sheets-PASO), a leading provider of information technology solutions for the healthcare industry is pleased to announce it has contracted with Partners in Care, an affiliate of the Visiting Nurse Service of New York. Since 1983, Partners in Care has provided certified home health aides and private-duty nurses who are experienced, compassionate, reliable, and highly attentive to the individuals in their care. Composed of more than 8,100 home health aides, RN’s and LPN’s, Partners in Care is accredited by the Community Health Accreditation Program (CHAP) and licensed by the New York State Department of Health.

The solution, based on PASHealth’s proprietary home healthcare Mobipen digital pen application, will pilot this month with key cluster homes in the Partners in Care organization and expand to other licensed users. Stage I of the implementation plan could have as many as 300 users, generating over $750,000.00 in income to the company. Field workers will be able to process paperwork in their usual work flow, while concurrently being able to digitally transfer the information back to the Partners in Care main office using the robust form capture infrastructure to interface patient data and caregiver digital note application.

United Treatment Centers, Inc. UTRM

Well, we were absolutely on target with our timing when it comes to re-alerting UTRM. We left this play alone for months while it sniffed out a bottom, and we called it to perfection!

Yesterday UTRM stock saw prices as high .0024, which would have represented 140% of intraday gains. The stock managed to close at .0015, holding 50% of its gains on the largest volume day of the past year!

We are so glad that it turned out exactly as we predicted, and do hope that some of you were able to catch the action and benefit.

This significant spike in volume in a strong indicator that many folks are out there accumulating UTRM at its bottom.

Blue Horseshoe Stock Report for 08/24/11

Patient Access Solutions, Inc. PASO

This is a play that we made mention of quite some time ago. Nothing really ever falls completely off of our radar, and we felt that it was time to bring this stock into the conversation once again based on a few factors. PASO ran as high as .0027 as recently as August, 3rd however, on Monday, hit its 52-week low.

In early December, the stock was .004, and ran fast to .0224, for a gain of 460%, so we know about the explosive potential in this play. For another example, in July we saw .0013 spike right up to .0027 for just over 100% gained.

Now that the stock has hit a new bottom, we are going to be on the lookout for spiking action similar to that which we have seen in the past.

For those who may not remember PASO is a medical record technology solutions provider with focused service within the healthcare community, of an overall focus of using modern technology to facilitate their client’s needs. Over a span fourteen years in the industry, PASHealth has developed a single sign-on, web-based, ASP platform which offers electronic medical verification and claims processing.

United Treatment Centers, Inc. UTRM

UTRM is another blast from the past this morning, as long as we’re dredging the old portfolio for hidden gems that are just waiting to be dusted off, and put back into rotation.

This stock also saw its 52-week low this week, yesterday bouncing up over 60% off of that bottom. From a technical standpoint, the RSI is showing signs of coming out of a huge oversold period, and in the past few days we have seen the stock priced as low as it ever has been.

Let’s not forget the past history on this play, one that has brought a run from .0035 to .0082 ( a gain of 134%) as well as one from .0018 to .0175, for a whopping 872% gain. We can only imagine the potential for monstrous gains from here at this extreme bottom.

Let’s not forget the other plays on our radars this week, DWIS, EMXC, and EXTO. We have not forgotten them, simply took a day’s hiatus present these bottom-fishing opportunities.

*In March of 2010, we received 750,000 restricted shares of UTRM from the company for a 3-Month Awareness Campaign. Please note the fact that we still own ALL 750,000, and have not sold a single share.